Methyl 2-[[2-fluoro-4-(6-phenacyloxy-2-pyridinyl)phenyl]methyl]-3-(2-methoxyethyl)benzimidazole-5-carboxylate
C32H28FN3O5 — CID 159733278
Data last refreshed: (MolForge compound catalog, from PubChem)
About Methyl 2-[[2-fluoro-4-(6-phenacyloxy-2-pyridinyl)phenyl]methyl]-3-(2-methoxyethyl)benzimidazole-5-carboxylate
Methyl 2-[[2-fluoro-4-(6-phenacyloxy-2-pyridinyl)phenyl]methyl]-3-(2-methoxyethyl)benzimidazole-5-carboxylate (PubChem CID 159733278) has the molecular formula C32H28FN3O5 and a molecular weight of 553.59 g/mol. Its IUPAC name is methyl 2-[[2-fluoro-4-(6-phenacyloxy-2-pyridinyl)phenyl]methyl]-3-(2-methoxyethyl)benzimidazole-5-carboxylate.
Molecular Properties
| Compound Name | Methyl 2-[[2-fluoro-4-(6-phenacyloxy-2-pyridinyl)phenyl]methyl]-3-(2-methoxyethyl)benzimidazole-5-carboxylate |
|---|---|
| PubChem CID | 159733278 |
| Molecular Formula | C32H28FN3O5 |
| Molecular Weight | 553.59 g/mol |
| Exact Mass | 553.20 |
| IUPAC Name | methyl 2-[[2-fluoro-4-(6-phenacyloxy-2-pyridinyl)phenyl]methyl]-3-(2-methoxyethyl)benzimidazole-5-carboxylate |
| SMILES | COCCn1c(Cc2ccc(-c3cccc(OCC(=O)c4ccccc4)n3)cc2F)nc2ccc(C(=O)OC)cc21 |
| InChI | InChI=1S/C32H28FN3O5/c1-39-16-15-36-28-18-24(32(38)40-2)13-14-27(28)34-30(36)19-22-11-12-23(17-25(22)33)26-9-6-10-31(35-26)41-20-29(37)21-7-4-3-5-8-21/h3-14,17-18H,15-16,19-20H2,1-2H3 |
| InChIKey | GWSHHGBBVZDVEP-UHFFFAOYSA-N |
| XLogP | 5.52 |
| TPSA | 92.54 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 11 |
| Heavy Atoms | 41 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 553.59 |
| LogP ≤ 5 | 5.52 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 159733278 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.